Why Scientists Hate Trump’s New Plan to Revamp Research Funding

Ah, the Trump administration has a new plan to 'revamp' research funding — because nothing says innovation like yanking money from universities and handing it to private companies who'll slap an 'AI-powered' sticker on a spreadsheet and call it research. The report proposes breaking from a 'decades-old system' that actually produced breakthroughs like the internet and mRNA vaccines, replacing it with a model where corporate boardrooms decide what counts as science. Because if there's one thing we've learned, it's that private companies are famously generous with long-term basic research when quarterly earnings are due.

The scientists, predictably, are 'hating' this. How dare they prefer a system that funds discovery over one that funnels taxpayer cash into shareholder dividends? The report claims AI-driven research will accelerate progress, which is a bit like saying replacing a library with a slot machine will improve literacy. The Chronicle quotes researchers warning that this shift could 'hollow out' academic science, but who needs decades of institutional knowledge when you can hire a consultant to tell you what to think?

The delightful irony is that Trump's own administration previously touted 'American leadership' in science, yet this plan essentially outsources that leadership to whoever can afford the best lobbyists. The 'AI-driven research' buzzword is a thin veil for what amounts to a corporate giveaway. Scientists hate it because they know what happens when market forces dictate discovery: you get patent wars, not cures. But sure, let's trust the invisible hand to guide us to the next Nobel Prize — after it's finished patenting the periodic table.